- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Takeda begins US layoffs as part of massive $1.3B restructuring | ||
| Mo | Samsung Biologics union gathers votes to strike as tension over wage, governance mounts | ||
| Mo | Biogen looks to shake up SMA status quo with FDA nod for high-dose version of Spinraza | ||
| 27.03. | 'Health Doesn't Need to Be Ludacris': Bayer signs rapper-actor to multivitamin campaign | ||
| 27.03. | Rocket charts measured trajectory for new gene therapy Kresladi after clearance to launch from FDA | ||
| 27.03. | Fierce Pharma Asia-Takeda's $1.3B reorg; India's GLP-1 floodgates; Gilead's $2.2B buy of a China NewCo | ||
| 26.03. | As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra | ||
| 26.03. | Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab | ||
| 26.03. | Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event | ||
| 26.03. | Outspoken ACIP member steps down amid vaccine panel uncertainty: reports | ||
| 25.03. | How pharma marketers can capitalize on HCPs' AI, social media and streaming habits | ||
| 25.03. | Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer | ||
| 25.03. | Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion | ||
| 25.03. | FDA approves Denali's Hunter syndrome drug, breaking streak of rare disease rejections | ||
| 25.03. | Novartis sued by breast cancer patient over branded drug websites' data-sharing practices | ||
| 25.03. | As Boehringer touts US launches, board chairman worries EU is 'falling further behind' | ||
| 25.03. | Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech | ||
| 25.03. | Takeda targets $1.3B in cost savings in further restructuring | ||
| 24.03. | UCB unveils plan to build huge biologics plant near its US headquarters in Atlanta | ||
| 24.03. | Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep | ||
| 24.03. | ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode | ||
| 24.03. | Cologuard campaign reunites 'Full House' stars to give 'The Talk' about colon cancer screening | ||
| 24.03. | Karyopharm, looking to jump start Expovio, reports mixed results in myelofibrosis | ||
| 24.03. | Lilly to remove certain insulin products from European markets by 2027 | ||
| 24.03. | Wilmington PharmaTech commits $50M to US API expansion |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.